The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 20

More JCP Articles

JCP
Lurasidone and Anxiety Symptoms in Bipolar Depression
Original Research

June 7, 2023

Lurasidone was superior to placebo at reducing anxiety in bipolar depression. Change in anxiety symptoms was predicted by sleep disturbance at baseline.
, , , et al
JCP
Understanding Misunderstandings About the Relative Risk and Odds Ratio
Clinical and Practical Psychopharmacology

June 5, 2023

Using simple concepts and arithmetic, Chittaranjan Andrade, MD, teaches readers how to derive and interpret relative risk and odds ratios.
JCP
JCP’s New Look
Editorial

June 5, 2023

Editor in Chief Marlene P. Freeman introduces readers to JCP’s updates.
JCP
Understanding 95% Confidence Intervals Around Relative Risk, Odds Ratio, and Hazard Ratio
Clinical and Practical Psychopharmacology

May 31, 2023

Dr Chittaranjan Andrade explains, in simple terms, an important concept: how to interpret 95% CIs for statistics expressed along an exponential scale.
JCP
Clinical Follow-Up and Widening LAI Intervals
Commentary

May 31, 2023

Although the administration intervals of long-acting injectable antipsychotics are a starting point for scheduling follow-ups, frequency of prescriber contact should be based on individual risk factors and real-world constraints.
, ,
JCP
Social Support and Symptoms of PTSD
Original Research

May 29, 2023

Social support affects the development and persistence of PTSD. A sense of belongingness to family and/or friends was associated with fewer PTSD symptoms in older adults.
, , , et al
JCP
Use of Medication With Depressive Symptom Side Effects
Original Research

May 24, 2023

MDD patients who used non-psychiatric medications with depressive side effects had higher odds of experiencing moderate to severe depressive symptoms.
, , , et al
JCP
Suicidal Ideation in Residential Substance Use Treatment
Original Research

May 22, 2023

People with substance use disorders (SUDs) and chronic health/psychiatric conditions may have higher risk for suicidal ideation than those with only SUD. Integrated treatments for patients with suicidal ideation…
, , , et al
JCP
Vortioxetine vs Desvenlafaxine in Patients With MDD
Original Research

May 22, 2023

Compared with desvenlafaxine, vortioxetine was associated with higher rates of symptomatic and functional remission, better daily and social functioning, and greater treatment satisfaction in patients with major depression and…
, , , et al
JCP
Predicting Remission From Depression in Youth Receiving Outpatient Medication Management
Original Research

May 17, 2023

Among 430 youth beginning treatment for depression, about one-quarter achieved remission within 6 months. The odds of remitting decreased as baseline symptom severity increased.
, , , et al
JCP
Cardiac Malformation Risks After First Trimester Methylphenidate Use
Brief Report

May 15, 2023

This meta-analysis found that use of methylphenidate in the first trimester may be a risk factor for fetal congenital heart defects.
, , , et al
JCP
Research Participant Feedback on a Suicide Safety Protocol
Original Research

May 15, 2023

In women who triggered a safety protocol as part of a perinatal suicidal ideation study, 50% reported that the protocol increased engagement with treatment, and most reported a “positive…
, , , et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe